Literature DB >> 25218726

Diabetes in China: mapping the road ahead.

.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25218726     DOI： 10.1016/S2213-8587(14)70189-5

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  7 in total

1.  Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme.

Authors:  S M Babineaux; B Curtis; T Holbrook; G Milligan; J Piercy
Journal:  BMJ Open       Date:  2016-08-16       Impact factor: 2.692

2.  Prevalence and determinants of depressive and anxiety symptoms in adults with type 2 diabetes in China: a cross-sectional study.

Authors:  Nianquan Sun; Peian Lou; Yan Shang; Pan Zhang; Jian Wang; Guiqiu Chang; Chunlei Shi
Journal:  BMJ Open       Date:  2016-08-16       Impact factor: 2.692

3.  Gender Difference in General Self-Efficacy among Young-Old Elderly Aged 60-74 in Rural Shandong China: A Cross-Sectional Survey.

Authors:  Yali Wang; Lingzhong Xu; Wenzhe Qin; Jiao Zhang; Yu Xia; Xiang Jing; Lu Lu; An'an Jiao; Yaozu Li
Journal:  Int J Environ Res Public Health       Date:  2019-12-12       Impact factor: 3.390

4.  Multimorbidity and catastrophic health expenditure among patients with diabetes in China: a nationwide population-based study.

Authors:  Yu Fu; Mingsheng Chen; Lei Si
Journal:  BMJ Glob Health       Date:  2022-02

5.  A higher-protein nut-based snack product suppresses glycaemia and decreases glycaemic response to co-ingested carbohydrate in an overweight prediabetic Asian Chinese cohort: the Tū Ora postprandial RCT.

Authors:  Louise W Lu; Marta P Silvestre; Ivana R Sequeira; Lindsay D Plank; Meika Foster; Nikki Middleditch; Alejandra Acevedo-Fani; Kieren G Hollingsworth; Sally D Poppitt
Journal:  J Nutr Sci       Date:  2021-04-23

Review 6.  A research agenda for aging in China in the 21st century.

Authors:  Evandro Fei Fang; Morten Scheibye-Knudsen; Heiko J Jahn; Juan Li; Li Ling; Hongwei Guo; Xinqiang Zhu; Victor Preedy; Huiming Lu; Vilhelm A Bohr; Wai Yee Chan; Yuanli Liu; Tzi Bun Ng
Journal:  Ageing Res Rev       Date:  2015-08-22       Impact factor: 10.895

7.  DUAL II China: Superior HbA1c reductions and weight loss with insulin degludec/liraglutide (IDegLira) versus insulin degludec in a randomized trial of Chinese people with type 2 diabetes inadequately controlled on basal insulin.

Authors:  Yu Pei; Bue R Agner; Bin Luo; Xiaolin Dong; Dongmei Li; Jun Liu; Lei Liu; Ming Liu; Yibing Lu; Tomoyuki Nishida; Xiangjin Xu; Yiming Mu
Journal:  Diabetes Obes Metab       Date:  2021-08-31       Impact factor: 6.408
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.